As seen by clinical correlation analysis, the reason for this discrepancy may be that high PDLIM2 expression contributes to the poor prognosis of LUSC patients by affecting lymph node metastasis. This evidence concerns the gene PDLIM2 and metastatic malignant neoplasm in the lymph nodes.